Human Longevity Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Human Longevity Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013535
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Human Longevity Inc (HLI) is a genomics-based, technology-driven company which develops database of whole genome, phenotype and clinical data. Its discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomarker and companion diagnostics. HLI primarily focuses on therapeutic areas such as cancer, diabetes and obesity, heart and liver diseases, and dementia. The company supports predictive, preventive and personalized care including the cancer analysis, integrated health analysis, newborn screening and rare, undiagnosed diseases through its genome sequencing and analysis. It works in collaboration with other organizations for the further discovery and development of novel therapeutics.HLI is headquartered in San Diego, California, the US.

Human Longevity Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Human Longevity Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Human Longevity Inc, Medical Devices Deals, 2011 to YTD 2017 9
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Human Longevity Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Human Longevity Acquires HiSeq X Ten Sequencing Systems From Illumina 11
Venture Financing 12
Celularity Raises Funds through Series A Financing 12
Human Longevity Raises US$70 Million In Venture Financing 13
Partnerships 14
Human Longevity Enters into Agreement with Merck 14
Cypher Genomics Enters into Research Agreement with Clinic for Special Children 15
Cypher Genomics Enters into Co-Development Agreement with Celgene 16
Cypher Genomics Enters into Co-Promotion Agreement with Illumina 17
Licensing Agreements 18
Human Longevity Enters into Licensing Agreement with Celgene Cellular Therapeutics for PSC-100 18
Acquisition 19
Human Longevity to Acquire LifebankUSA from Celgene Cellular Therapeutics 19
Human Longevity Inc – Key Competitors 20
Human Longevity Inc – Key Employees 21
Human Longevity Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
May 25, 2017: Saturnino Fanlo Joins Human Longevity As Chief Financial Officer 23
May 02, 2017: Human Longevity Enhances Senior Leadership Team, Making Key Hires to Strengthen Commercialization and Operations 24
Jan 04, 2017: Human Longevity Hires Cynthia Collins, Healthcare Industry Leader, as New Chief Executive Officer 26
Apr 06, 2016: Human Longevity Announces Promotions and Additions to Leadership Team 28
Product News 30
Aug 21, 2017: Celularity Accelerates Breakthrough Placental Discovery & Therapeutic Platform 30
Jul 03, 2017: Human Longevity Researchers Develop New Algorithm to Rapidly and Accurately Predict HLA Types Using Illumina Next Generation Sequencing Technology 31
Mar 06, 2017: In Largest Whole Genome Sequence Analysis Study, Human Longevity-Led Team Identifies Common-to-Rare Variants in the Human Blood Metabolome 32
Jan 12, 2016: Human Longevity to Offer Oncology Products Including Comprehensive Whole Germline, Tumor Genome and Whole Cancer Exome Products 33
Other Significant Developments 34
May 11, 2017: Human Longevity, Inc. Launches Pilot Program, Health Nucleus X 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Human Longevity Inc, Pharmaceuticals & Healthcare, Key Facts 2
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Human Longevity Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Human Longevity Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Human Longevity Inc, Medical Devices Deals, 2011 to YTD 2017 9
Human Longevity Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Human Longevity Acquires HiSeq X Ten Sequencing Systems From Illumina 11
Celularity Raises Funds through Series A Financing 12
Human Longevity Raises US$70 Million In Venture Financing 13
Human Longevity Enters into Agreement with Merck 14
Cypher Genomics Enters into Research Agreement with Clinic for Special Children 15
Cypher Genomics Enters into Co-Development Agreement with Celgene 16
Cypher Genomics Enters into Co-Promotion Agreement with Illumina 17
Human Longevity Enters into Licensing Agreement with Celgene Cellular Therapeutics for PSC-100 18
Human Longevity to Acquire LifebankUSA from Celgene Cellular Therapeutics 19
Human Longevity Inc, Key Competitors 20
Human Longevity Inc, Key Employees 21
Human Longevity Inc, Other Locations 22
Human Longevity Inc, Subsidiaries 22

★海外企業調査レポート[Human Longevity Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cantex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cantex Pharmaceuticals Inc (Cantex), formerly ParinGenix Inc is a clinical stage biopharmaceutical company that focuses on the development of proprietary pharmaceuticals for the treatment of cancers and other disorders. The company's pipeline products include CX-01, a proprietary combination …
  • iKang Healthcare Group Inc:企業の戦略・SWOT・財務情報
    iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report Summary iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Checkpoint Therapeutics Inc (CKPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Checkpoint Therapeutics Inc (Checkpoint Therapeutics), a subsidiary of Fortress Biotech Inc, is a clinical-stage biopharmaceutical company that acquires, develops and commercializes non-chemotherapy and immune enhanced combination treatments for the treatment of solid tumor cancers. The comp …
  • Epcor Utilities Inc:企業の戦略的SWOT分析
    Epcor Utilities Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Hydro-Electric Corporation:電力:M&Aディール及び事業提携情報
    Summary Hydro-Electric Corporation (Hydro Tasmania) is a state owned integrated energy utility. It generates electricity and supplies that on wholesale and retail basis. The company produces power using hydro, gas, wind and solar sources. Hydro Tasmania also retails gas to business and residential c …
  • Japan Foods Co Ltd:企業の戦略・SWOT・財務分析
    Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MedStar Health:企業の戦略的SWOT分析
    MedStar Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • GlaxoSmithKline Plc (GSK):医療機器:M&Aディール及び事業提携情報
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervo …
  • Questerre Energy Corp (QEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Questerre Energy Corp (Questerre) is an independent oil and gas exploration and development company that acquires, explores, develops and produces unconventional oil and gas properties. The company’s unconventional properties include tight oil, shale oil and shale gas. It has base production …
  • Polyplus-Transfection SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops RNA interference such as STICKY SIRNA and SIRNAPLUS for in vivo research. It …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Xilinx, Inc.:企業の戦略・SWOT・財務分析
    Xilinx, Inc. - Strategy, SWOT and Corporate Finance Report Summary Xilinx, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Flower Orthopedics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Flower Orthopedics Corp (Flower Orthopedics) is a medical equipment provider that offers orthopedic devices. The company offers instrument kits which include K-wire kits, olive wire kits, guide wire kits, drill bit kits, lag screw kits, cannulated drill bits, trials and cannulated countersin …
  • Bush Industries Inc
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ono Pharmaceutical Co Ltd (4528):製薬・医療:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • Zynerba Pharmaceuticals Inc (ZYNE):製薬・医療:M&Aディール及び事業提携情報
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-psychoactive cannabinoid, formu …
  • Alabama Power Co:企業の発電所・SWOT分析2018
    Alabama Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • W. R. Grace & Co:企業の戦略・SWOT・財務情報
    W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report Summary W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Finning International Inc. (FTT):企業の財務・戦略的SWOT分析
    Finning International Inc. (FTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Symbiotec Pharmalab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆